These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12660075)

  • 1. The COOPERATE trial.
    Krüger B; Böger C; Stubanus M; Fischereder M; Krämer BK
    Lancet; 2003 Mar; 361(9362):1054; author reply 1055. PubMed ID: 12660075
    [No Abstract]   [Full Text] [Related]  

  • 2. The COOPERATE trial.
    Presne C; Mansour J; Makdassi R; Choukroun G; Fournier A
    Lancet; 2003 Mar; 361(9362):1054; author reply 1055. PubMed ID: 12660076
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of combined treatment with enalapril and losartan on myocardial function in heart failure.
    Cocco G; Kohn S; Jerie P
    Heart; 2002 Aug; 88(2):185-6. PubMed ID: 12117852
    [No Abstract]   [Full Text] [Related]  

  • 4. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
    Nakao N; Yoshimura A; Morita H; Takada M; Kayano T; Ideura T
    Lancet; 2003 Jan; 361(9352):117-24. PubMed ID: 12531578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy.
    Nakao N; Seno H; Kasuga H; Toriyama T; Kawahara H; Fukagawa M
    Am J Nephrol; 2004; 24(5):543-548. PubMed ID: 15528874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy for hypertension associated with kidney disease].
    Suzuki H
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 9. Fixed-dose combination therapy in the treatment of hypertension: ready for prime time.
    Basile JN
    South Med J; 2007 Apr; 100(4):343-4. PubMed ID: 17458389
    [No Abstract]   [Full Text] [Related]  

  • 10. ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(4):215-7. PubMed ID: 23199543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New options against undertreatment].
    Pfeffer M
    MMW Fortschr Med; 2003 Dec; 145(49):18. PubMed ID: 14963987
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a therapy with losartan and quinaprilat on the progression of chronic renal failure in rats after a single dose of uranyl nitrate or 5/6 nephrectomy.
    Appenroth D; Beutinger R; Lupp A; Fleck C
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):359-66. PubMed ID: 12877346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment for hypertension in patients with renal diseases].
    Nakamura S
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():452-9. PubMed ID: 15179937
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and chronic captopril or Losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats.
    Martínez LA; Villalobos-Molina R
    Arch Med Res; 2003; 34(5):357-61. PubMed ID: 14602500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.
    Hou FF; Xie D; Zhang X; Chen PY; Zhang WR; Liang M; Guo ZJ; Jiang JP
    J Am Soc Nephrol; 2007 Jun; 18(6):1889-98. PubMed ID: 17494885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.